Australia’s competition watchdog has warned private health insurers they must fulfil their commitment to return all profits due to COVID-19 to policyholders, raising concerns over conservative calculations put forward by some health funds.
Read More
ACCC says US-style managed care ‘unlikely’ in final Honeysuckle ruling
Australia’s competition watchdog has delivered its final ruling allowing the formation of the Honeysuckle Health buying group, however it has prevented the involvement of four major health funds that represent 70% of the market.
Read More
Read More
‘Managed care’ concerns as ACCC authorises Honeysuckle buying group
An interim decision to allow a new buying group to collectively negotiate contracts with healthcare providers is a defining moment in Australian healthcare, says the Australian Society of Ophthalmologists (ASO), which is spearheading a challenge against the introduction of “US-style managed care”.
Read More
Read More
Fears new buying group could limit patient freedom
The creep of US-style managed care in Australia and reduced competition in the optical market are among major concerns raised with the competition watchdog as it considers the formation of a new buying group to collectively negotiate contracts with healthcare providers.
Read More
Glaucoma treatments change hands under pharmaceutical merger
A proposed merger between two pharmaceutical companies that compete in the glaucoma treatment markets has been given the green light – with one major stipulation.
Read More
Read More
Oscar Wylee penalised $3.5 million
Australian eyewear retailer Oscar Wylee has been ordered to pay $3.5 million in penalties for misleading or deceptive conduct and making false or misleading representations about its charitable donations and affiliations.
Read More
Read More
ACCC concludes investigation, clears Ellex-Lumibird deal
The Australian competition watchdog has cleared Ellex Medical Lasers’s $100 million sale of its laser and ultrasound business to Lumibird, with the transaction now expected to be completed as early as this week.
Read More
Read More
ACCC launches probe into Ellex-Lumibird deal
The Australian competition authority is examining Ellex Medical Lasers’s proposed $100 million sale of its laser and ultrasound business to Lumibird to consider its impact on market competition and the pricing of related ophthalmic devices.
Read More
Read More